Skip to main content
  • 2909 Accesses

Abstract

Lung volume reduction surgery (LVRS) is a viable option for a select group of emphysema patients. Effective preoperative pulmonary rehabilitation and careful patient selection criteria promote favorable outcomes. Effective perioperative pain management and early extubation are significant factors that minimize postoperative complications and lead to better outcome. LVRS improves dyspnea and exercise tolerance and increases potential for patient survival in appropriately selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Prevalence and incidence of chronic obstructive pulmonary disease. 2010. http://www.cureresearch.com/c/copd/prevalence.html. Accessed 24 Jan 2010.

  2. Brantigan OC, Mueller E, Kress MB. A surgical approach to pulmonary emphysema. Am Rev Respir Dis. 1959;80(1 Pt. 2):194–206.

    CAS  PubMed  Google Scholar 

  3. Cooper JD, Lefrak SS. Is volume reduction surgery appropriate in the treatment of emphysema? Yes. Am J Respir Crit Care Med. 1996;153:1201–4.

    Article  CAS  PubMed  Google Scholar 

  4. McKenna RJ Jr, Benditt JO, DeCamp M, et al. Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery. J Thorac Cardiovasc Surg. 2004;127:1350–60.

    Article  PubMed  Google Scholar 

  5. National Emphysema Treatment Trial Group. Rationale and design of the national emphysema treatment trial (NETT): a prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg. 1999;118:518–28.

    Article  Google Scholar 

  6. Carrell RW, Jeppsson JO, Laurell CB, et al. Structure and variation of the human alpha-1-antitrypsin. Nature. 1982;298:329–34.

    Article  CAS  PubMed  Google Scholar 

  7. Janus ED, Phillips NT, Carrell RW. Smoking, lung function and alpha-1-antitrypsin deficiency. Lancet. 1985;1:152–4.

    Article  CAS  PubMed  Google Scholar 

  8. Potter WA, Olafsson S, Hyatt RE. Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease. J Clin Invest. 1971;50:910–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Stubbing DC, Pengelly LD, Morse JLC, et al. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol. 1980;49:511–5.

    Article  CAS  PubMed  Google Scholar 

  10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987;136:225–44.

    Article  Google Scholar 

  11. Buist AS, Sexton GJ, Nagy JM, Ross BB. The effect of smoking cessation and modification on lung function. Am Rev Respir Dis. 1976;114:115–22.

    CAS  PubMed  Google Scholar 

  12. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy volume reduction for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1995;109:106–19.

    Article  CAS  PubMed  Google Scholar 

  13. Hughes RL, Davison R. Limitations of exercise reconditioning in COPD. Chest. 1983;83:241–9.

    Article  CAS  PubMed  Google Scholar 

  14. Sahn SA. Corticosteroid therapy in chronic obstructive pulmonary disease. Pract Cardiol. 1985;11(8):150–6.

    Google Scholar 

  15. Tager I, Speizer FE. Role of infection in chronic bronchitis. N Engl J Med. 1975;292:563–71.

    Article  CAS  PubMed  Google Scholar 

  16. Anthonisen NR. Long-term oxygen therapy. Ann Intern Med. 1983;99:519–27.

    Article  CAS  PubMed  Google Scholar 

  17. Nocturnal Oxygen Therapy Trail Group. Continuous or nocturnal oxygen therapy in hypoxemia chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;91:391–8.

    Google Scholar 

  18. Tuxen DV, Lane S. The effects of ventilatory pattern on hyperinflation, airway pressures, and circulation in mechanical ventilation of patients with severe air-flow obstruction. Am Rev Respir Dis. 1987;136:872–9.

    Article  CAS  PubMed  Google Scholar 

  19. Weinmann GG, Hyatt R. Evaluation and research in lung volume reduction surgery. Am J Respir Crit Care Med. 1996;154:1913–8.

    Article  CAS  PubMed  Google Scholar 

  20. Daniel TM, Barry BK, Chan MD, et al. Lung volume reduction surgery: case selection, operative technique, and clinical results. Ann Surg. 1996;223(5):526–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Wisser W, Klepetko W, Senbaklavaci O, et al. Chronic hypercapnia should not exclude patients from lung volume reduction surgery. Eur J Cardiothorac Surg. 1998;14:107–12.

    Article  CAS  PubMed  Google Scholar 

  22. Thurnheer R, Muntwyler J, Stammberger U, et al. Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest. 1997;112(1):122–8.

    Article  CAS  PubMed  Google Scholar 

  23. Hamacher J, Block KE, Stammberger U, et al. Two years’ outcome of lung volume reduction surgery in different morphologic emphysema types. Ann Thorac Surg. 1999;68:1792–8.

    Article  CAS  PubMed  Google Scholar 

  24. Rogers RM, Coxson HO, Sciurba FC, et al. Preoperative severity of emphysema predictive of improvement after lung volume reduction surgery – use of CT morphometry. Chest. 2000;118:1240–7.

    Article  CAS  PubMed  Google Scholar 

  25. Salzman SH. Can CT measurement of emphysema severity aid patient selection for lung volume reduction surgery? Chest. 2000;118:1231–2.

    Article  CAS  PubMed  Google Scholar 

  26. Thurnheer R, Engel H, Weder W, et al. Role of lung perfusion scintigraphy in relation to chest computed tomography and pulmonary function in the evaluation of candidates for lung volume reduction surgery. Am J Respir Crit Care Med. 1999;159(1):301–10.

    Article  CAS  PubMed  Google Scholar 

  27. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med. 2001;345(15):1075–83.

    Article  Google Scholar 

  28. Dueck R, Cooper S, Kapelanski D, Colt H, Clauser J. A pilot study of expiratory flow limitation and lung volume reduction surgery. Chest. 1999;116:1762–71.

    Article  CAS  PubMed  Google Scholar 

  29. Gelb AF, Zamel N, McKenna RJ, Brenner M. Mechanism of short-term improvement in lung function after emphysema resection. Am J Respir Crit Care Med. 1996;154:945–51.

    Article  CAS  PubMed  Google Scholar 

  30. Marchand E, Gayan-Ramirez G, De Leyn P, Decramer M. Physiological basis of improvement after lung volume reduction surgery for severe emphysema: where are we? Eur Respir J. 1999;13(3):686–96.

    Article  CAS  PubMed  Google Scholar 

  31. Sciurba FC, Rogers RM, Keenan RJ, Slivka WA, Gorcsan J, Ferson PF, Holbert JM, Brown ML, Landreneau RJ. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med. 1996;334:1095–9.

    Article  CAS  PubMed  Google Scholar 

  32. Tschernko EM, Wisser W, Hofer S, et al. Influence of lung volume reduction on ventilatory mechanics in patients suffering from severe COPD. Anesth Analg. 1996;83:996–1001.

    Article  CAS  PubMed  Google Scholar 

  33. Ingenito EP, Evans RB, Loring SH, et al. Relation between preoperative inspiratory lung resistance and the outcome of lung-volume-reduction surgery for emphysema. N Engl J Med. 1998;338:1181–5.

    Article  CAS  PubMed  Google Scholar 

  34. Tschernko EM, Kritzinger M, Gruber EM, et al. Lung volume reduction surgery: preoperative functional predictors for postoperative outcome. Anesth Analg. 1999;88:28–33.

    CAS  PubMed  Google Scholar 

  35. Tutic M, Lardinois D, Imfeld S, et al. Lung – volume reduction surgery as an alternative or bridging procedure to lung transplantation. Ann Thorac Surg. 2006;82:208–13.

    Article  PubMed  Google Scholar 

  36. The National Emphysema Treatment Trial Research Group. Effects of lung volume reduction surgery versus medical therapy: results from the National Emphysema Treatment Trial. N Engl J Med. 2003;324:2059–73.

    Google Scholar 

  37. Naunheim KS, Wood DE, Mohnsenifar Z, et al. Long-term follow-up of patients receiving lung-volume reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg. 2006;82:431–3.

    Article  PubMed  Google Scholar 

  38. Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet. 2003;361:931–3.

    Article  PubMed  Google Scholar 

  39. Yim AP, Hwong TM, Lee TW, et al. Early results of endoscopic lung volume reduction for emphysema. J Thorac Cardiovasc Surg. 2004;127:1564–73.

    Article  PubMed  Google Scholar 

  40. Salanitri J, Kalff V, Kelly M, et al. 133Xenon ventilation scintigraphy applied to bronchoscopic lung volume reduction techniques for emphysema: relevance of interlobar collaterals. Int Med J. 2005;35:97–103.

    Article  CAS  Google Scholar 

  41. Reilly J, Washko G, Pinto-Plata V, et al. Biological lung volume reduction: a new bronchoscopic therapy for advanced emphysema. Chest. 2007;131:1108–13.

    Article  PubMed  Google Scholar 

  42. Shah PL, van Geffen WH, Desiee G, Slebos D-J. Lung volume reduction for emphysema. Lancet Respir Med. 2017;5:147–56.

    Article  PubMed  Google Scholar 

  43. Weinberg M, Hendeles L. Methylxanthines. In: Weiss EB, Segal MS, Stein M, editors. Bronchial asthma. Mechanisms and therapeutics. 2nd ed. Boston: Little Brown and Company; 1985.

    Google Scholar 

  44. Ballantyne JC, Carr DB, deFerranti S, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998;86(3):598–612.

    Article  CAS  PubMed  Google Scholar 

  45. Warner DO. Preventing postoperative pulmonary complications. Anesthesiology. 2000;92:1467–72.

    Article  CAS  PubMed  Google Scholar 

  46. Keenan DJM, Cave K, Langdon L, et al. Comparative trial of rectal indomethacin and cryoanalgesia for control of early postthoracotomy pain. Br Med J. 1983;287:1335.

    Article  CAS  Google Scholar 

  47. Karmakar MJ. Thoracic paravertebral block. Anesthesiology. 2001;95:771–80.

    Article  CAS  PubMed  Google Scholar 

  48. Hill SE, Keller RA, Stafford-Smith M, et al. Efficacy of single-dose, multilevel paravertebral nerve blockade for analgesia after thoracoscopic procedures. Anesthesiology. 2006;104:1047–53.

    Article  CAS  PubMed  Google Scholar 

  49. Loehning RW, Waltemath CL, Bergman NA. Lidocaine and increased respiratory resistance produced by ultrasonic aerosols. Anesthesiology. 1976;44:306–10.

    Article  CAS  PubMed  Google Scholar 

  50. Brandus V, Joffe S, Benoit CV, et al. Bronchial spasm during general anesthesia. Can Anesth Soc J. 1970;17:269–74.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Erin A. Sullivan .

Editor information

Editors and Affiliations

Clinical Case Discussion

Clinical Case Discussion

Case: A 58-year-old female patient with end-stage emphysema is scheduled for bilateral LVRS using a video-assisted thoracoscopic approach (VATS). She has a past medical history that is significant for smoking (60 pack years; quit for the past 2 years), hypertension, and atrial fibrillation that is controlled with metoprolol. Her other medication includes an 81-mg aspirin that she takes once per day. She successfully completed a preoperative exercise program 8 weeks ago. The patient is very anxious and wishes to speak with the anesthesiologist who will provide her care prior to the date of surgery.

Questions

  • What additional preoperative preparation is necessary from a pulmonary standpoint?

  • How will you treat the patient’s anxiety?

  • What will you recommend for perioperative pain management?

  • What are your specific concerns regarding postoperative management?

Preoperative Pulmonary Preparation

  • Successful completion of a preoperative exercise program including a 6-min walk on a flat surface, bicycle ergometer, and weight lifting (see section “Preoperative Medical Management of Emphysema Patients”).

  • Continue supplemental oxygen use, bronchodilators, and mucolytics up to and including the day of surgery (see section “Pharmacologic Preparation”).

  • Gradually reduce the dose of steroids prior to surgery if they are being administered.

  • If the patient is receiving theophylline therapy and exhibiting symptoms of toxicity (nervousness, tremor, tachycardia) or if serum levels exceed 20 ng/mL, discontinue the drug.

  • Ensure that the patient is free from infection and does not require antibiotics for at least a 3-week period prior to surgery.

Treatment of Anxiety

  • Untreated anxiety may precipitate an episode of acute bronchospasm, an increase in dynamic pulmonary hyperinflation, and dyspnea (see section “Preoperative Medical Management of Emphysema Patients”).

  • An effective way to allay a patient’s anxiety is for the anesthesiologist to establish a good relationship with the patient prior to the date of surgery by scheduling a meeting in the anesthesia preoperative evaluation clinic.

  • Anxiolytic therapy may be necessary during the preoperative and perioperative period.

Perioperative Analgesia

  • The patient is at high risk for perioperative pulmonary complications if analgesia is insufficient or ineffective.

  • The risk of pulmonary complications may be improved with the use of thoracic epidural or paravertebral analgesia (see sections “Thoracic Epidural Analgesia” and “Paravertebral Nerve Block”).

  • TEA or paravertebral nerve block catheters should be maintained until the chest drains are removed and the patient is tolerating oral pain medications.

Postoperative Management (see sections “Early Extubation” and “Postoperative Management”)

  • Air leakage can be exacerbated by positive pressure ventilation. Therefore, the patient should be extubated as soon as it is safe to do so, preferably in the operating room. It is safe, however, to maintain mechanical ventilation for 1–2 h following surgery, and this is preferable to premature extubation and the subsequent development of arterial hypoxemia.

  • Fifty percent of LVRS patients develop a postoperative complication.

  • Reintubation and mechanical ventilation in the postoperative period are associated with a high morbidity and mortality.

  • Postoperative complications can be minimized by implementing judicious pulmonary toilet, bronchodilator therapy, effective pain management with thoracic epidural or paravertebral analgesia, and avoidance of systemic corticosteroids.

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sullivan, E.A. (2019). Lung Volume Reduction. In: Slinger, P. (eds) Principles and Practice of Anesthesia for Thoracic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-00859-8_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-00859-8_46

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-00858-1

  • Online ISBN: 978-3-030-00859-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics